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doi:10.1016/j.ejvs.2011.09.003Abstract Aim: To evaluate contrast-enhanced ultrasound (CEUS) as an effective alternative
to CT-angiography (CTA) for endoleak detection and aneurismal sac diameter measurement in
the follow-up after endovascular abdominal aortic aneurysm repair (EVAR).
Methods: From January 2006 to December 2010, 395 patients underwent EVAR follow-up with
both CTA and CEUS. The diameter of the aneurismal sac and the presence of endoleaks were
evaluated in all the 395 paired examinations.
Results: BlandeAltman plots showed a good agreement in aneurismal sac diameter evaluation
between the two imaging modalities. The mean diameter was 54.93 mm (standard deviation
(SD) 12.57) with CEUS and 56.01 mm (SD  13.23) with CTA. The mean difference in aneur-
ismal sac diameter was 1.08 mm  3.3543 (95% confidence interval (CI), 0.75 to 1.41), in
favour of CTA. The number of observed agreement in endoleak detection was 359/395
(90.89%). The two modalities detected the same type I and type III endoleaks. McNemar’s c2
test confirmed that CTA and CEUS are equivalent in endoleak detection.
Conclusions: CEUS demonstrated to be as accurate as CTA in endoleak detection and abdom-
inal aortic aneurysm diameter measurements during EVAR follow-up, without carrying the risks
of radiation exposure or nephrotoxicity. Even if it cannot be proposed as the sole imaging
modality during follow-up, our analysis suggests that it should have a major role.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Endovascular repair of abdominal aortic aneurysm (AAA)
was introduced more than 20 years ago1 as a minimally
invasive option to treat infrarenal AAAs. Since then, endo-
vascular abdominal aortic aneurysm repair (EVAR) has0 445 005; fax: þ33 320 445811.
hru-lille.fr (S. Haulon).
ty for Vascular Surgery. Publishegained widespread acceptance. Although conceived and
initially used to treat patients deemed to be at high risk for
conventional open surgery, recent randomised controlled
trials have shown at least a short-term advantage for EVARd by Elsevier Ltd. All rights reserved.
798 P. Perini et al.in fit patients.2e5 On the other hand, EVAR has been asso-
ciated with a higher incidence of secondary interventions
due to endoleak, migration or kinking. A strict follow-up is
therefore mandatory for early detection e and correction e
of these issues to avoid more severe complications.
Computed tomography angiography (CTA) is considered,
at present, the gold standard for EVAR follow-up, but has
several important drawbacks such as cumulative radiation
dose and subsequent risk of malignancies, nephrotoxic
contrast agent load and high costs6 that can limit its use as
a lifelong surveillance tool. Some authors indicated that
colour duplex ultrasound (US) can be used for post-EVAR
follow-up,7e9 but a systematic review by Ashoke et al.10
highlighted that US alone is insufficient in endoleak
detection. Contrast-enhanced ultrasound (CEUS) seems to
be a highly sensitive modality for endoleak detection and
EVAR surveillance,11 but the available literature is, at
present, still scant.
In our present single-centre study, we prospectively
collected and analysed 395 patients who underwent EVAR
and were subsequently followed up with both CTA and
CEUS. The efficacy of the two techniques in endoleak
detection and aneurismal sac diameter measurement was
compared.
Materials and Methods
Patients and study design
The study enrolled all patients who underwent EVAR for
abdominal aortic aneurysms at our institution and for whom
a follow-up with CTA and CEUS was undertaken, during the
period from January 2006 to December 2010. The time
interval between the two examinations was <15 days. If
a patient had repeated follow-up with both CEUS and CTA,
we only included the first CEUS that was performed and
compared it to the corresponding CTA.
EVAR was performed with Zenith (Cook Medical, Bloo-
mington, IA, USA), Talent (Medtronic, Santa Rosa, CA, USA),
Anaconda (Vascutek, Terumo, Inchinnan, Scotland) or
Fenestrated endografts (Cook Medical). All cases were
performed in a dedicated operating theatre with an OEC
9900 Elite MD Imaging System (GE Healthcare, Salt Lake
City, UT, USA).
This study was approved by the Ethical Review Board of
our institution, and written informed consent was obtained
from all patients.
CTA
All the CTAs were performed in our institution with a 64-
slice CT scanner (Philips Brilliance 64 CT scanner, Philips
Healthcare, Amsterdam, Netherlands). Triple-phase acqui-
sition with unenhanced and contrast-enhanced in arterial
(with bolus tracking) and delayed phases (at 70 s) was
carried out from the thorax to the femoral bifurcations.
Contrast medium (100 ml of Iomeron 350 Bracco SA, Milano,
Italy or Omnipaque 350, Amersham Health, Princeton, NJ,
USA) was injected through a 18-gauge cannula in an ante-
cubital vein with the use of a power injector (Envision,
Medrad, Pittsburgh, PA, USA) at a rate of 4.5 ml s1,followed by 40 ml of saline solution injected at a rate of
4.5 ml s1. A region of interest in the proximal abdominal
aorta was used to monitor the bolus; the scan started 6 s
after the enhancement of this region had crossed the
threshold trigger of 200HU. Further data acquisition
parameters were 0.625 mm detectors, 120 kVp and 250 mA,
reconstructed at 1-mm thickness every 0.7 mm. Patients
with renal insufficiency were prepared for CTA with intra-
venous hydration before and after the examination.
Patients with a history of iodinated contrast media allergy
were pre-medicated with oral corticosteroids and antihis-
tamines before the examination.
The CTAs were analysed on an independent dedicated
workstation (Aquarius, TeraRecon, San Matteo, CA, USA) by
both vascular surgeons and vascular radiologists (who were
blinded to the results of CEUS, if already performed) to
determine the maximal aortic diameter by centreline
measurements and to depict and characterise endoleaks.
Both diagnostic techniques (CTA and CEUS) were also used
to identify patency and proper graft placement (features
not analysed in this study).
CEUS
All US scans were performed by three angiologists experi-
enced in vascular ultrasonography and in the use of ultra-
sound contrast material who were blinded to CTA findings
at the time of examination. These scans were performed
with three instruments: a Philips iE33 (Philips Healthcare,
Amsterdam, Netherlands), a Vivid 7 and a Vivid 9 (GE
Healthcare, Salt Lake City, UT, USA) equipped with
a convex 3.5-Mhz probe. A typical US examination started
with standard B-mode investigation to measure the aneu-
rysm sac diameter (outer wall to outer wall, dimensions
recorded as the mean of three measurements). Then, the
blood flows from the main body of the endograft to the
femoral arteries were analysed with pulse wave modality.
In the setting of a fenestrated or multibranched endograft,
the visceral arteries were also evaluated (a feature not
analysed in this study). CEUS was then performed after the
administration of a bolus of ½ bottle (2.5 ml) of SonoVue
(Bracco, Milan, Italy e the only second-generation contrast
agent approved in France), flushed with an injection of a 5-
ml bolus of isotonic saline solution through an intravenous
cannula. Endoleak detection was performed at a low
mechanical index (0.2e0.3) and with the focus positioned
behind the aorta to delay bubble destruction. If the 6-min
time frame allowed by this bolus was insufficient to prop-
erly detect or characterise the endoleak, the rest of the
bottle of contrast media was injected with the same
modalities in order to complete the examination.
We have classified the endoleaks according to the
‘Reporting standards for endovascular aortic aneurysm
repair’ published in 2002.12
Statistics
The maximal external aneurysm sac diameter was
measured with both diagnostic techniques, and data were
expressed as mean  standard deviation (SD). Comparison
of size measurements between CTA and CEUS was
Figure 1 Bland and Altman Plot of the data (maximal aneu-
rysmsacdiameter) obtained from395paired examinations (CEUS
and CTA). Only 19 data points (4.81%) are outside the limits of
agreement. The regression line of differences is drawn in black
(Equation of the trendline y Z 0.0516xþ1.7828; Correlation
CoefficientZ 0.1968,p< 0.001; Intercept CoefficientZ 1.7828;
SlopeZ 0.0516, p < 0.001).
Figure 2 Linear correlation for diameter measurements with
CEUS and CTA is observed.
Single-centre Prospective Comparison 799performed by BlandeAltman plots.13 A McNemar’s c2 test
was performed to identify differential endoleak detection
by the two imaging modalities.
Results
In the period from January 2006 to December 2010, 614
patients underwent EVAR in our centre. The following
patients were excluded from this study: 61 patients who
underwent thoracic endografting, 17 with severe contrast
media allergy and 22 with severe renal insufficiency. In
addition, 83 refused enrolment in the current study.
We enrolled in this prospective study 431 patients who
underwent subsequent follow-up with both CEUS and CTA in
our institution. Thirty-six potential paired examinations
were excluded from this comparative analysis for one of the
following reasons: time interval between CEUS and CTA >15
days as a consequence of logistic problems (n Z 35) and
failure to perform CEUS because of intervening bowel gas
(n Z 1). Overall, 395 patients and as many paired exami-
nations were available for comparative analysis. The paired
imaging was performed less than 1 month after the proce-
dure (typically before discharge) in 274 patients (69.4%),
and during follow-up (median 18.55 months, range 35 days
to 9 years after the procedure) in 121 patients (30.6%).
EVAR was performed with 308 bifurcated endografts
(77.97%), 31 aorto-uni-iliac (7.85%) and 56 fenestrated
endografts (14.18%). Endografts were manufactured by
Cook (386/395 grafts, 97.72%), Medtronic (7/395, 1.77%) or
Vascutek (2/395, 0.51%).
All patients completed the follow-up, and no adverse
events were recorded during these examinations.
AAA diameter
The mean diameters of the abdominal aortic aneurysm sac
at follow-up were 54.93 mm (SD  12.57) with CEUS and
56.01 mm (SD  13.23) with CTA. The mean difference in
aneurismal sac diameter was 1.08 mm  3.3543 (95%
confidence interval (CI), 0.75 to 1.41), in favour of CTA.
The agreement between maximal external aneurysm sac
diameter measurements by CTA and CEUS was represented
in BlandeAltman plots (Fig. 1), which showed a good
agreement between the two imaging modalities (only 4.81%
of data points were outside the limits of agreement). The
regression line of differences confirmed this agreement
(correlation coefficient: 0.1968, p < 0.001) showing
a minimal slope of the trendline (slope Z 0.0516,
p < 0.001).
Agreement between measurements obtained from the
two methods was confirmed by the correlation coefficient
(correlation R Z 0.967, p < 0.001; slope of the
trendlineZ 1.0179, p < 0.001; intercept e the point where
the trendline intersects the y-axis Z 0.0989) (Fig. 2).
Endoleaks
Endoleaks were detected by CTA in 25.06% (99/395
patients) and by CEUS in 26.08% (103/395). Endoleaks were
detected by both imaging modalities in 83 patients (Table
1). The number of observed agreements was 359/395(90.89%) (Figs. 3 and 4). McNemar’s c2 test confirmed that
the two methods are equivalent. In fact, with a c2 value of
0.25 the null hypothesis cannot be rejected (p > 0.5).
Analysing more in detail the ability of the two tech-
niques in detecting the endoleaks according to their type,
we noticed that the majority of detected endoleaks were
type II endoleaks (Table 2), and were found in 20.76% of the
patients with CEUS, and in 19.75% of the patients with CTA.
CEUS detected 21 type II endoleaks that were not shown by
CTA and CTA showed 17 type II endoleaks that were not
detected with CEUS (McNemar’s c2 value Z 0.2368,
p > 0.5, the two imaging modalities have to be considered
as equivalent). The two modalities detected the same type
I and type III endoleaks. No type IV endoleaks were
detected in this study.Discussion
CTA is considered, at present, the gold standard for
radiologic follow-up after EVAR.14 Unfortunately, CT scan
presents several important disadvantages that are exacer-
bated by the lifelong surveillance needed for these
patients. The radiation dose of a thoraco-abdominal CT
scan is more than 20 mGy,15 and a standard follow-up
performed only with this modality equates to a total
effective radiation dose of around 145e205 mSv over 5
years16 with a subsequent, significant, higher risk of cancer.
Nephrotoxic contrast agent load causes an important renal
Table 1 Endoleaks detected with CTA and CEUS.
CTAþ CTA Total
CEUSþ 83 20 103
CEUS 16 276 292
Total 99 296 395
800 P. Perini et al.function decline during long-term follow-up (significantly
greater if compared to open repair);17 preservation of renal
function is vital to obtain favourable long-term outcomes18
and must be pursued. Moreover, high costs represent an
additional limitation for its widespread use in lifelong
surveillance.6
For these reasons, a safer and more cost-effective
alternative to CTA is an issue that must be addressed.
This alternative tool, to be effective, should be able to
provide information about the maximal diameter of the
aneurysm, occurrence of endoleaks, migration of the
endograft, component separation, kinking and thrombosis
of graft limbs with a high sensitivity and specificity.
Colour duplex ultrasound is less expensive and does not
carry the risks associated with ionising radiations or
contrast-induced renal insufficiency. For these reasons, it
has been investigated as an alternative to CTA for EVARFigure 3 Visualization of a type 2 endoleak with CEUS (a,
transverse scan, harmonic) and CTA (b, axial MPR view).
Figure 4 A type II endoleak perfused by the Inferior
Mesenteric Artery. a) Power-Doppler image of the endoleak,
longitudinal scan. b) MIP view of the same endoleak on post-
operative CTA.follow-up. Even if this modality proved to be highly accu-
rate during EVAR follow-up in diameter measurements20 (an
element that is suggestive of endoleak), an initial system-
atic review by Ashoke et al.10 and a recent systematic
review and bivariate meta-analysis by Mirza et al.11 high-
lighted that non-CEUS lacks sufficient diagnostic accuracy
for sole use in endoleak detection. Moreover, US perfor-
mance could be poorer in the presence of unfavourable
body habitus such as obesity, coexistent pathology like
ascites or excessive intervening bowel gas, endoprosthesis
factors such as echo reflection from the stent graft and
slow endoleak flow.Table 2 Classification of the endoleaks detected with
CEUS and CTA.
Endoleak CEUS CTA
No endoleak 292 296
Type I 18 18
Type II 82 78
Type III 3 3
Type IV 0 0
Single-centre Prospective Comparison 801All these drawbacks can be minimised by the use of
contrast media.11,21 These stabilised microbubbles of
sulphur hexafluoride gas (that is eliminated through the
respiratory system) surrounded by a phospholipidic shell
improve blood flow echogenicity by resonating with low-
intensity US, which enhances backscatter and thereby
increases the detected signal. Second-generation ultraso-
nographic contrast agents are safe agents for which no
adverse events such as nephrotoxicity have been
described.11
Literature evaluating CEUS in EVAR follow-up is still
scant, especially if compared to the data available on
unenhanced ultrasound. In fact, the largest amount of
data is provided by the systematic review and bivariate
meta-analysis by Mirza et al.11 published in 2010, which
suggests that CEUS has superior sensitivity compared to
unenhanced ultrasound for the detection of endoleaks
after EVAR. Mirza et al.11 analysed 21 studies with a total
of 2601 patients for the unenhanced US group, and only
seven studies and 288 patients in the CEUS group.
Considering also the two studies published after this
review by Ten Bosch et al.22 and by Cantisani et al.,19
which present 83 and 108 patients, respectively, the
total number of paired examinations comparing CEUS to
CTA is, at present, 479 in nine different studies. Moreover,
these studies present a high degree of heterogeneity in the
existing evidence, and Mirza et al.11 concluded that
further research is required.
So far, our study provides the largest case series of
patients followed up with both CTA and CEUS, showing that
the two techniques have the same efficacy in endoleak
detection, with a number of observed agreements of 359/
395 (90.89%). The equivalence of the two imaging modali-
ties was confirmed by the McNemar’s c2 test (c2 Z 0.25,
p > 0.5, the null hypothesis of ‘marginal homogeneity’
cannot be rejected).
There are limitations in CEUS examinations that cannot
be e apparently e minimised by the use of contrast
media. First of all, the well-known operator dependency
of US examinations might limit the reproducibility of the
results. However, as demonstrated by the interobserver
analysis in the study by Ten Bosch et al.,22 variability in
AAA sac diameter measurements was low if performed by
well-trained operators. Second, factors such as obesity,
ascites or intervening bowel gas might interfere with US
imaging. However, in the present study, only one CEUS
was unsuccessful (and therefore the patient was
excluded), indicating that fasting associated to a new-
generation ultrasonic imaging device can overcome this
issue and obtain an adequate visualisation of the AAA.
Another potential drawback of CEUS might be the inability
to detect stent-strut failure, kinking of the limbs or
migration of the endoprosthesis. Plain abdominal X-ray, in
two to four projections, provides all of this information;
the radiation dose is about 1 mSv and the subsequent risk
of cancer therefore negligible.15 The higher rate of
endoleak detection (especially type II endoleaks) with
CEUS compared to CTA is not to be considered as a ‘false
positive’, but represents its higher sensitivity in the
detection of true low-flow endoleaks (this may be
explained by the continuous real-time scanning opposed
to the two static temporal angiographic images inCTA).22,23 Also in our study, CEUS detected a higher
number of endoleaks compared to CTA. However, this
difference did not reach statistical significance, and our
statistical analysis indicated that the two methods are
equivalent.
Finally, CEUS allows better classification of endoleaks19
since it has the advantage to provide haemodynamic
information on blood-flow direction in addition to the
possibility to compare, in real-time and on the same
screen, the baseline and the contrastographic images.
Defining inflow and outflow vessels perfusing the endoleak
is of potential interest in preinterventional planning of
transarterial embolisation.
The shrinkage or the growth of the aneurismal sac refers
to elements that are suggestive of successful aneurysm
exclusion. Thus, AAA sac diameter measurement during
EVAR follow-up is mandatory. In our experience, US and
CEUS demonstrated to be as accurate as the CT for AAA sac
measurements: BlandeAltman analysis of aneurysm sac
diameter demonstrated good agreement between the two
imaging modalities.
The role of post-EVAR surveillance is also to guide re-
intervention. CT provides superior information related to
graft anchoring, kinking and integrity or aneurysm
morphologic changes including aneurismal degeneration of
the iliac arteries. It is thus mandatory to perform a new CT
for proper planning in case of re-intervention.
In accordance with the recent literature,11,19,22
providing a significantly larger number of patients, this
study indicates that CEUS has demonstrated to be at least
as accurate as CTA in post-EVAR follow-up, especially if
associated to plain X-ray. CEUS cannot be proposed for the
sole imaging modality during EVAR surveillance, particularly
if a re-intervention is needed, but it can surely replace
most of the CTA reducing the ionising radiation load and the
risk of renal insufficiency. In our centre, CEUS has already
replaced the 6-month and 24-month (and yearly thereafter)
CTA scheduled in the standard post-EVAR surveillance
protocol, and we are planning to further reduce the number
of CTA in the future.Conclusions
An ideal surveillance protocol is supposed to have an
optimal sensitivity and specificity for the detection of
possible complications without posing an extra health risk
to the patient, and finally has to be cost-effective. CEUS
has demonstrated to be as accurate as CTA in endoleak
detection and AAA sac diameter measurements during EVAR
follow-up, and does not carry the risks associated to radi-
ation exposure and nephrotoxicity. Furthermore, it is
cheap, fast, and can be repeated frequently. CEUS, in
association with plain abdominal X-ray, should replace most
CTAs performed during post-EVAR surveillance. CTA is still
necessary for proper endovascular planning in case of re-
intervention.Conflict of Interest/Funding
None.
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